Cargando…

State of the art in neoadjuvant therapy of breast cancer

Detalles Bibliográficos
Autores principales:	Minckwitz, Gunter von, Fontanella, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041314/ https://www.ncbi.nlm.nih.gov/pubmed/26217146 http://dx.doi.org/10.1016/j.ejcsup.2013.07.043

Ejemplares similares

Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents
por: Untch, Michael, et al.
Publicado: (2009)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study
por: Halfter, Kathrin, et al.
Publicado: (2015)

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy
por: Issa-Nummer, Yasmin, et al.
Publicado: (2014)

Ablative Therapies for Breast Cancer: State of Art
por: Carriero, Serena, et al.
Publicado: (2023)

PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
por: Guo, Sanxing, et al.
Publicado: (2020)

Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques
por: Heil, Joerg, et al.
Publicado: (2015)

State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments
por: Honig, Arnd, et al.
Publicado: (2005)

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives
por: Caparica, Rafael, et al.
Publicado: (2019)

Neoadjuvant chemotherapy in advanced-stage ovarian cancer – state of the art
por: Margioula-Siarkou, Chrysoula, et al.
Publicado: (2022)

Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial
por: Issa-Nummer, Yasmin, et al.
Publicado: (2013)

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy
por: Marinovich, M L, et al.
Publicado: (2013)

Outcome after neoadjuvant chemotherapy in elderly breast cancer patients – a pooled analysis of individual patient data from eight prospectively randomized controlled trials
por: von Waldenfels, Gabriel, et al.
Publicado: (2018)

Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives
por: Imperatori, Marco, et al.
Publicado: (2016)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
por: Kang, Jin, et al.
Publicado: (2021)

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
por: Denkert, Carsten, et al.
Publicado: (2013)

Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023)

Molecularly Targeted Therapies for Gastric Cancer. State of the Art
por: Reddavid, Rossella, et al.
Publicado: (2021)

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer
por: Glaser, Rebecca L., et al.
Publicado: (2014)

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
por: Marinovich, Michael L., et al.
Publicado: (2015)

Recent advances in neoadjuvant therapy for breast cancer
por: Potter, David A, et al.
Publicado: (2021)

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy
por: Sinn, Bruno Valentin, et al.
Publicado: (2019)

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2016)

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars
por: Kolberg, Hans-Christian, et al.
Publicado: (2019)

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer
por: Wenners, Antonia Sophie, et al.
Publicado: (2012)

Effect of neoadjuvant therapy on breast cancer biomarker profile
por: Rey-Vargas, Laura, et al.
Publicado: (2020)

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2009)

Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
por: Laakmann, Elena, et al.
Publicado: (2019)

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis
por: Loibl, Sibylle, et al.
Publicado: (2011)

Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2013)

Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy
por: Park, Cheol Keun, et al.
Publicado: (2016)

Neoadjuvant Therapy in Nonmetastatic Breast Cancer in Kurdistan, Iraq
por: Namiq, Karez Sarbast, et al.
Publicado: (2023)

Neoadjuvant Endocrine Therapy (NET) in breast cancer – COVID setting
por: Bardoli, Antonio, et al.
Publicado: (2022)

State-of-the-Art Digital Imaging in Dentistry: Advanced Research of MRI, CT, CBCT, and Digital Intraoral Imaging
por: Honda, Eiichi, et al.
Publicado: (2018)

Breast surgery: state of the art
por: Kissin, M
Publicado: (2006)

Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
por: Gazet, J. C., et al.
Publicado: (1996)

Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
por: Conte, PierFranco, et al.
Publicado: (2020)

Editorial: The State of the Art in Creative Arts Therapies
por: Shafir, Tal, et al.
Publicado: (2020)

miR-205 in Breast Cancer: State of the Art
por: Plantamura, Ilaria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ecbirm4vqctsl1bj54ulikk0o